Use of compound 1 in treatment or prevention of renal fibrosis and other diseases
AssigneeShenzhen Newdel Biotech Co., Ltd.
InventorsXun HE, Feng JIN, Yuhan GUO, Tianyuan ZHANG, Zhenwei LI, Wei HU
Life of this patent
Estimating the term…
Abstract
The present invention relates to use of N-(3-chloro-5-(trifluoromethyl)phenyl)-3-((6-(4-hydroxypiperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)ethynyl)-2-methylbenzamide (also referred to herein as compound 1) or a pharmaceutically acceptable salt thereof in the treatment or prevention of renal fibrosis and other diseases.
Claims5
Use of compound 1 or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating or preventing renal fibrosis, wherein compound 1 has the following structure:
Use of compound 1 or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating or preventing a disease mediated by DDR1 or that may be controlled by inhibiting DDR1, wherein compound 1 has the following structure:
Use of compound 1 or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating or preventing a disease mediated by DDR2 or that may be controlled by inhibiting DDR2, wherein compound 1 has the following structure:
Use of compound 1 or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating or preventing a disease mediated by EPHA6 or that may be controlled by inhibiting EPHA6, wherein compound 1 has the following structure:
Use of compound 1 or a pharmaceutically acceptable salt thereof in the manufacture of a medicament for treating or preventing a disease mediated by CSF1R or that may be controlled by inhibiting CSF1R, wherein compound 1 has the following structure:
Dependencies are inferred from the claim text.